SAN FRANCISCO — Attorneys from Latham & Watkins in Silicon Valley and San Francisco are advising Berkeley-based pharmaceutical company Plexxikon Inc. in an acquisition worth up to $935 million by one of Japan’s largest drug companies, Daiichi Sankyo Co.
Silicon Valley corporate partners Alan Mendelson, Peter Kerman, Joshua Dubofsky and Gregory Chin led the deal team, along with associates Benjamin Potter, Mark Bekheit and Elizabeth Sharma.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
